Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Alimuddin Zumla and Giuseppe Ippolito.
Alimuddin Zumla
Connection Strength
6.840
Giuseppe Ippolito
  1. Toning down the 2019-nCoV media hype-and restoring hope. Lancet Respir Med. 2020 03; 8(3):230-231.
    View in: PubMed
    Score: 0.867
  2. Looking for pathways related to COVID-19: confirmation of pathogenic mechanisms by SARS-CoV-2-host interactome. Cell Death Dis. 2021 08 12; 12(8):788.
    View in: PubMed
    Score: 0.240
  3. COVID-19 disease-Temporal analyses of complete blood count parameters over course of illness, and relationship to patient demographics and management outcomes in survivors and non-survivors: A longitudinal descriptive cohort study. PLoS One. 2020; 15(12):e0244129.
    View in: PubMed
    Score: 0.230
  4. Lessons from the COVID-19 Pandemic-Unique Opportunities for Unifying, Revamping and Reshaping Epidemic Preparedness of Europe's Public Health Systems. Int J Infect Dis. 2020 12; 101:361-366.
    View in: PubMed
    Score: 0.228
  5. COVID-19 and tuberculosis-threats and opportunities. Int J Tuberc Lung Dis. 2020 08 01; 24(8):757-760.
    View in: PubMed
    Score: 0.224
  6. Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19). Cell Death Differ. 2020 11; 27(11):3196-3207.
    View in: PubMed
    Score: 0.222
  7. Reducing mortality and morbidity in patients with severe COVID-19 disease by advancing ongoing trials of Mesenchymal Stromal (stem) Cell (MSC) therapy - Achieving global consensus and visibility for cellular host-directed therapies. Int J Infect Dis. 2020 Jul; 96:431-439.
    View in: PubMed
    Score: 0.221
  8. Is Africa prepared for tackling the COVID-19 (SARS-CoV-2) epidemic. Lessons from past outbreaks, ongoing pan-African public health efforts, and implications for the future. Int J Infect Dis. 2020 04; 93:233-236.
    View in: PubMed
    Score: 0.217
  9. Pulmonary Involvement during the Ebola Virus Disease. Viruses. 2019 08 24; 11(9).
    View in: PubMed
    Score: 0.210
  10. Non-inferiority versus superiority trial design for new antibiotics in an era of high antimicrobial resistance: the case for post-marketing, adaptive randomised controlled trials. Lancet Infect Dis. 2019 12; 19(12):e444-e451.
    View in: PubMed
    Score: 0.210
  11. Early improvement of glycaemic control after virus clearance in patients with chronic hepatitis C and severe liver fibrosis: a cohort study. New Microbiol. 2019 Jul; 42(3):139-144.
    View in: PubMed
    Score: 0.208
  12. High-income countries and latent tuberculosis infection screening for migrants - Authors' reply. Lancet Infect Dis. 2019 07; 19(7):691-692.
    View in: PubMed
    Score: 0.208
  13. Latent tuberculosis infection: diagnostic tests and when to treat. Lancet Infect Dis. 2019 03; 19(3):231-233.
    View in: PubMed
    Score: 0.203
  14. Tuberculin skin test - Outdated or still useful for Latent TB infection screening? Int J Infect Dis. 2019 Mar; 80S:S20-S22.
    View in: PubMed
    Score: 0.202
  15. Monkeypox - Enhancing public health preparedness for an emerging lethal human zoonotic epidemic threat in the wake of the smallpox post-eradication era. Int J Infect Dis. 2019 Jan; 78:78-84.
    View in: PubMed
    Score: 0.199
  16. Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis. 2018 07; 18(7):e183-e198.
    View in: PubMed
    Score: 0.190
  17. Taking forward the Stop TB Partnership and World Health Organization Joint Theme for World TB Day March 24th 2018 - "Wanted: Leaders for a TB-Free World. You can make history. End TB". Int J Infect Dis. 2018 03; 68:122-124.
    View in: PubMed
    Score: 0.190
  18. Is there sufficient evidence to repeal three decades of clinical research on chronic hepatitis C? Clin Microbiol Infect. 2018 Apr; 24(4):328-331.
    View in: PubMed
    Score: 0.187
  19. Enhancing preparedness for tackling new epidemic threats. Lancet Respir Med. 2017 08; 5(8):606-608.
    View in: PubMed
    Score: 0.179
  20. The global dynamics of diabetes and tuberculosis: the impact of migration and policy implications. Int J Infect Dis. 2017 Mar; 56:45-53.
    View in: PubMed
    Score: 0.176
  21. The Middle East Respiratory Syndrome Coronavirus - A Continuing Risk to Global Health Security. Adv Exp Med Biol. 2017; 972:49-60.
    View in: PubMed
    Score: 0.175
  22. Short-term economic impact of the Zika virus outbreak. New Microbiol. 2016 Oct; 39(4):287-289.
    View in: PubMed
    Score: 0.172
  23. Taking forward a 'One Health' approach for turning the tide against the Middle East respiratory syndrome coronavirus and other zoonotic pathogens with epidemic potential. Int J Infect Dis. 2016 Jun; 47:5-9.
    View in: PubMed
    Score: 0.168
  24. Zika virus and microcephaly: is the correlation causal or coincidental? New Microbiol. 2016 Apr; 39(2):83-5.
    View in: PubMed
    Score: 0.166
  25. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Int J Mol Sci. 2021 Apr 26; 22(9).
    View in: PubMed
    Score: 0.059
  26. Evidences for lipid involvement in SARS-CoV-2 cytopathogenesis. Cell Death Dis. 2021 03 12; 12(3):263.
    View in: PubMed
    Score: 0.058
  27. The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients. Int J Infect Dis. 2021 Apr; 105:49-53.
    View in: PubMed
    Score: 0.058
  28. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases. Front Immunol. 2020; 11:610300.
    View in: PubMed
    Score: 0.057
  29. An Inflammatory Profile Correlates With Decreased Frequency of Cytotoxic Cells in Coronavirus Disease 2019. Clin Infect Dis. 2020 11 19; 71(16):2272-2275.
    View in: PubMed
    Score: 0.057
  30. Postmortem Findings in Italian Patients With COVID-19: A Descriptive Full Autopsy Study of Cases With and Without Comorbidities. J Infect Dis. 2020 11 09; 222(11):1807-1815.
    View in: PubMed
    Score: 0.057
  31. Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome. Cell Death Dis. 2020 10 27; 11(10):921.
    View in: PubMed
    Score: 0.057
  32. Frequency and Duration of SARS-CoV-2 Shedding in Oral Fluid Samples Assessed by a Modified Commercial Rapid Molecular Assay. Viruses. 2020 10 20; 12(10).
    View in: PubMed
    Score: 0.057
  33. Epidemic and pandemic viral infections: impact on tuberculosis and the lung: A consensus by the World Association for Infectious Diseases and Immunological Disorders (WAidid), Global Tuberculosis Network (GTN), and members of the European Society of Clinical Microbiology and Infectious Diseases Study Group for Mycobacterial Infections (ESGMYC). Eur Respir J. 2020 10; 56(4).
    View in: PubMed
    Score: 0.057
  34. Immune responses during COVID-19 infection. Oncoimmunology. 2020 08 25; 9(1):1807836.
    View in: PubMed
    Score: 0.056
  35. Mortality in COVID-19 disease patients: Correlating the association of major histocompatibility complex (MHC) with severe acute respiratory syndrome 2 (SARS-CoV-2) variants. Int J Infect Dis. 2020 Sep; 98:454-459.
    View in: PubMed
    Score: 0.056
  36. Immunological and inflammatory profiles in mild and severe cases of COVID-19. Nat Commun. 2020 07 08; 11(1):3410.
    View in: PubMed
    Score: 0.056
  37. COVID-19: viral-host interactome analyzed by network based-approach model to study pathogenesis of SARS-CoV-2 infection. J Transl Med. 2020 06 10; 18(1):233.
    View in: PubMed
    Score: 0.055
  38. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy? J Intern Med. 2020 10; 288(4):410-421.
    View in: PubMed
    Score: 0.055
  39. The immune system of children: the key to understanding SARS-CoV-2 susceptibility? Lancet Child Adolesc Health. 2020 06; 4(6):414-416.
    View in: PubMed
    Score: 0.055
  40. Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma. Lancet. 2020 04 04; 395(10230):1096-1099.
    View in: PubMed
    Score: 0.055
  41. Coronavirus infections: Epidemiological, clinical and immunological features and hypotheses. Cell Stress. 2020 Mar 02; 4(4):66-75.
    View in: PubMed
    Score: 0.054
  42. 2019-novel Coronavirus severe adult respiratory distress syndrome in two cases in Italy: An uncommon radiological presentation. Int J Infect Dis. 2020 Apr; 93:192-197.
    View in: PubMed
    Score: 0.054
  43. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health - The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020 02; 91:264-266.
    View in: PubMed
    Score: 0.054
  44. Latent TB Infection (LTBI) - Mycobacterium tuberculosis pathogenesis and the dynamics of the granuloma battleground. Int J Infect Dis. 2019 Mar; 80S:S58-S61.
    View in: PubMed
    Score: 0.051
  45. Improving treatment outcomes for MDR-TB - Novel host-directed therapies and personalised medicine of the future. Int J Infect Dis. 2019 Mar; 80S:S62-S67.
    View in: PubMed
    Score: 0.050
  46. Relationship Between Viremia and Specific Organ Damage in Ebola Patients: A Cohort Study. Clin Infect Dis. 2018 01 06; 66(1):36-44.
    View in: PubMed
    Score: 0.047
  47. A large ongoing outbreak of hepatitis A predominantly affecting young males in Lazio, Italy; August 2016 - March 2017. PLoS One. 2017; 12(11):e0185428.
    View in: PubMed
    Score: 0.046
  48. Human Zika infection induces a reduction of IFN-? producing CD4 T-cells and a parallel expansion of effector Vd2 T-cells. Sci Rep. 2017 07 24; 7(1):6313.
    View in: PubMed
    Score: 0.045
  49. Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient. PLoS Pathog. 2017 01; 13(1):e1006065.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.